Metoclopramide hydrochloride (Reglan) is a widely prescribed drug for treatment of upper gastrointestinal symptoms. Although the drug is relatively safe, a growing body of literature has noted movement disorders after its administration. We have reported six cases of metoclopramide-induced parkinsonism seen in consultation over a two-year period. Five of these six patients had renal failure. Their parkinsonism improved on discontinuation of metoclopramide therapy. Metoclopramide-induced parkinonism is not rare, and appropriate dose reduction in patients with renal failure will help reduce the incidence of this morbidity.
|Original language||English (US)|
|Number of pages||2|
|Journal||Southern Medical Journal|
|State||Published - Jan 1 1989|
ASJC Scopus subject areas